Since the first-in-human trials utilizing radiolabeled antibodies targeted toward PD-L1/PD-1 were reported (8, 9), clinical imaging [recently reviewed by Hegi-Johnson et al. (3)] of PD-L1 expression in human cancer has expanded. The gene discussed is CD274; the disease is cancer.